Risk stratification in transthyretin-related cardiac amyloidosis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,667 followers.

Risk stratification in transthyretin-related cardiac amyloidosis https://t.co/0nyuahKMGu

14 Apr 2023

Reply Repost Favourite

RT @CMRPapers: Risk stratification in transthyretin-related cardiac amyloidosis https://t.co/gnMr1cNpmv

08 Apr 2023

Reply Repost Favourite

Risk stratification in transthyretin-related cardiac amyloidosis https://t.co/gnMr1cNpmv

08 Apr 2023

Reply Repost Favourite

New Research: Risk stratification in transthyretin-related cardiac amyloidosis: Transthyretin related cardiac amyloidosis (TTR-CA) is an infiltrative cardiomyopathy that cause heart failure with preserved ejection fraction, mainly in… https://t.co/O3HcUqcd

21 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.